Barbara Widom is an Endocrinology/Metabolic physician. OpenAlex indexes 8 publications with 509 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1106 E Prospect Rd
Suite 100
Fort Collins, CO 805255306
Telephone
970-224-3636Registry record last updated 26 Jan 2015.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- KYOWA KIRIN, INC.Program year20251 payment
- Pacira Pharmaceuticals IncorporatedProgram year20251 payment
- Kyowa Kirin, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
77.1%Other drugs affecting bone structure and mineralization54.1%Romosozumab-aqqg100%Part B, office-administered≥12 patientsRANK Ligand Inhibitor23%Denosumab100%Part B, office-administered≥40 patientsMetabolism & gastrointestinal
9.5%GLP-1 receptor agonist2.9%Mounjaro79%Trulicity13%Ozempic8%Part D<11 patientsInsulin Analog2.9%Tresiba Flextouch U-10017%Novolog Flexpen12%Humalog Kwikpen U-10011%Insulin Lispro Kwikpen U-1009%Tresiba Flextouch U-2008%Toujeo Solostar7%Lantus Solostar7%Insulin Lispro6%Novolog6%Fiasp Flextouch5%Humalog5%Toujeo Max Solostar5%Lantus3%Part D<11 patients+ 7 more classes in this area
Hormonal (systemic)
7.2%l-Thyroxine6.1%Levothyroxine Sodium84%Synthroid16%Part D≥206 patientsThyroid Hormone Synthesis Inhibitor0.6%Methimazole100%Part D≥30 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Cognitive function in patients with insulin-dependent diabetes mellitus during hyperglycemia and hypoglycemia
The American Journal of Medicine
1995 - Stimulus specificity of defects in counterregulatory hormone secretion in insulin-dependent diabetes mellitus: effect of glycemic control.
The Journal of Clinical Endocrinology & Metabolism
1994 - Effect of the Menstrual Cycle on Glucose Metabolism and Diabetes Control in Women with Insulin-Dependent Diabetes Mellitus
Seminars in Reproductive Medicine
1994
Similar KOLs
Other experts from the same institution or the same specialty.
Bruce Bartholow Duncan
Universidade Federal do Rio Grande do Sul
Alireza Esteghamati
Tehran University of Medical Sciences
Paul Zimmet
Monash University
André Pascal Kengne
South African Medical Research Council
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”